What is the main business of Cezalmed?

The main business activity of Cezalmed focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 24, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Solec 18, 00-410 Warszawa.

Who is on the management board?

The management board consists of: Tomasz Puchalski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $86,299, representing a decrease of 19.0% compared to 2023.

Is the company profitable?

Yes, the company recorded a net profit of $22,144 in 2024, meaning the company decreased its profit by 46.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $33,126 in 2024, representing 53% of all operating expenses.

Cezalmedsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-07-24

Share capital

6 000,00 PLN

Registered address

ul. Solec 18/B21, 00-410 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

2025not filed
202412/06/2025
202302/07/2024
202230/06/2023
202129/06/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 86.30kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 22.14kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 62.11kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 155.99kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Tomasz Puchalski – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Marcin Puchalskiage 46	110	$1,485.68	91.6667%
Others	10	$135.06	8.3333%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2020-08-31.

mBank
72 1140 2004 0000 3602 8092 8136

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl

Change history

Date	Event
2021-02-03	Name change (Meru → Cezalmed)
2021-02-03	PKD change (Removed: 45, 49, 68, 70.22.Z, 73; Added: 46.46.Z, 58, 62, 71, 72)
2020-07-24	Entered in the register

FAQ

Last updated: 2026-04-20